Skip to main content

Pro Kapital Council approved Consolidated Interim Report for IV Quarter and 12 Months of 2025 (Unaudited)

MANAGEMENT REPORT Real Estate Development Tallinn During the fourth quarter of 2025 we completed the construction of the white building in our Uus- Kindrali project, located in Kristiine City, Tallinn. Client inspections and the signing of real rights agreements commenced in November, and by year-end, we had successfully closed 39 residential units in the white building. The remaining pre-sold units are scheduled to be closed during the first quarter of 2026. By the end of the reporting period, corresponding with the completion of construction, 78% of the sellable area (m²) had been sold. At the same time, the construction activities continued on a second seven-storey residential building with 90 units, located next to the white building at Sammu Street 10 / Seebi Street 24a, Tallinn. By the year end all the windows had been installed;...

Continue reading

Bonduelle – Statement of availability of the Half-Year Financial Report on December 31, 2025

BONDUELLE  Head office: “La Woestyne” – 59173 Renescure – FranceBonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 eurosRegistered under number: 447 250 044 (Dunkerque Commercial and Companies Register)Villeneuve d’Ascq, on February 27, 2026 Statement of availability of the Half-Year Financial Report on December 31, 2025 The company today announces that it released its Half Year Report on December 31, 2025 and filed the report at the AMF. The Half Year Report is available on the website of the company at the following address: www.bonduelle.com under the topic “Investors / Regulated information” (https://www.bonduelle.com/en/investors/regulated-information/).AttachmentStatement of availability of HY 25-26 Financial report

Continue reading

Afarak Group: FINANCIAL STATEMENTS RELEASE 2025

09:00 London, 11:00 Helsinki, 27 February 2026 – Afarak Group SE (“Afarak” or “the Company”) (LSE: AFRK, NASDAQ: AFAGR) FINANCIAL STATEMENTS RELEASE 2025    H2/25 H2/24 FY2025 FY2024Revenue  EUR million  64.2 57.2 141.3 128.6EBITDA EUR million -7.1 -1.6 -0.2 2.6EBIT EUR million -8.5 -3.2 -2.6 -0.1Earnings before taxes EUR million -11.0 -7.2 -7.5 -5.3Loss for the period EUR million -11.4 -7.8 -8.9 -7.2Earnings per share EUR -0.04 -0.03 -0.03 -0.03EBITDA margin % -11.1 -2.9 -0.2 2.0EBIT margin % -13.3 -5.6 -1.8 -0.1Earnings margin % -17.1 -12.5 -5.3 -4.1Personnel (end of period)   626 602 626 602SECOND HALF 2025 HIGHLIGHTSRevenue for the second half of 2025 increased to EUR 64.2 (H2/2024: 57.2) million; Speciality Alloys processed material sold increased by 32.7%, to 13,053...

Continue reading

Vallourec Fourth Quarter 2025 Results

Meudon (France), February 27th, 2026 Vallourec, a world leader in premium seamless tubular solutions, announces today its results for the fourth quarter 2025. The Board of Directors of Vallourec SA, meeting on February 26th 2026, approved the Group’s fourth quarter 2025 Consolidated Financial Statements.  Fourth Quarter 2025 ResultsQ4 Group EBITDA of €214 million, strong 21% EBITDA margin Excellent total cash generation of €177 million Around €650 million distribution to shareholders targeted by August 2026a Q1 2026 Group EBITDA expected to range between €165 million and €195 million Resilient US customer demand while imports continue to decline Early signs of activity rebound in key Middle East marketsHIGHLIGHTS Fourth Quarter 2025 ResultsGroup EBITDA of €214 million, up 2% sequentially, EBITDA margin remained strong at 21%Tubes...

Continue reading

FRO – Fourth Quarter and Full Year 2025 Results

FRONTLINE PLC REPORTS RESULTS FOR THE FOURTH QUARTER ENDED DECEMBER 31, 2025 Frontline plc (the “Company”, “Frontline,” “we,” “us,” or “our”), today reported unaudited results for the three and twelve months ended December 31, 2025: HighlightsProfit of $227.9 million, or $1.02 per share for the fourth quarter of 2025. Adjusted profit of $230.4 million, or $1.03 per share for the fourth quarter of 2025. Declared a cash dividend of $1.03 per share for the fourth quarter of 2025. Reported revenues of $624.5 million for the fourth quarter of 2025. Achieved average daily spot time charter equivalent earnings (“TCEs”)1 for VLCCs, Suezmax tankers and LR2/Aframax tankers in the fourth quarter of $74,200, $53,800 and $33,500 per day, respectively. Entered into agreements to sell eight of our oldest first-generation ECO VLCCs, built...

Continue reading

Luotea’s Financial Statements Release 2025: The partial demerger was completed at year end; significant profitability improvement in continuing operations in 2025

Luotea PlcStock exchange release27 February 2026 at 8:00 a.m Luotea Plc: Financial Statements Release 1 January – 31 December 2025 The partial demerger was completed at year‑end; significant profitability improvement in continuing operations in 2025 The Circular economy business of Lassila & Tikanoja Plc was separated on 31 December 2025 through a partial demerger into an independent company, which was named the New Lassila & Tikanoja Plc. Luotea Plc continues the Facility Services Business. The company’s Extraordinary General Meeting approved the partial demerger on 4 December 2025. In this financial statement release, Luotea Plc presents the Circular Economy Business as Discontinued Operations in accordance with IFRS 5. Comparative periods have been adjusted accordingly. Presentation in accordance with IFRS 5 does not reflect...

Continue reading

Lassila & Tikanoja Plc Financial Statements Release January – December 2025

Lassila & Tikanoja PlcStock exchange release 27 February 2026 at 8.00 AM EET OPERATIONS AS AN INDEPENDENT LISTED COMPANY BEGAN, SOLID PERFORMANCE CONTINUED The financial information presented in this Financial Statements Release is based on actual figures as at 31 December 2025 for the statement of financial position, and on carve‑out financial information for other financial information and comparative periods. The carve‑out financial information does not necessarily reflect what the combined results of operations, financial position or cash flows would have been had Lassila & Tikanoja operated as an independent legal group and prepared separate consolidated financial information for the periods presented. Nor does the carve‑out financial information necessarily indicate the future results of operations, financial position or...

Continue reading

13/2026・Trifork Group: 2025 annual report and interim report for the quarter ending 31 December 2025

Schindellegi, Switzerland – 27 February 2026 Trifork Group AGCompany announcement no. 13/2026 2025 annual report and interim report for the quarter ending 31 December 2025 Trifork Group reports full-year 2025 revenue growth of 7.2% and adj. EBITDA margin of 13.6% with accelerated organic revenue growth and strong margin improvement in the fourth quarter. A EURm 10 share buyback will be initiated. A strategic review of options for Trifork Labs has been initiated. Comment from Group CEO Jørn Larsen “We delivered solid organic growth of 7.0% in 2025 and 9.4% in Q4. As expected, margins improved toward year-end, and we finished within the full-year guidance set a year ago. We expect the positive momentum to continue in 2026, with record revenue and profits. As part of our product-led transition, we have introduced a new reporting structure...

Continue reading

Ackermans & van Haaren ends a successful year 2025 with a net profit of 593 million euros (+29%)

Dear shareholder, Dear Madam, Dear Sir,Please find attached our press release with the FY2025 Results:Outstanding results at DEME, Delen Private Bank, Bank Van Breda and SIPEF boost net profit to 592.5 million euros. Equity strengthens to 5.7 billion euros, delivering a 10.3% return on equity Proposal to increase the dividend to 4.60 euros per share (+21%)Best regards Ackermans & van HaarenAttachmentAvH ends a successful year 2025 with a net profit of 593 million euros

Continue reading

Ryoncil® Profits Underpinning Substantial Growth Pipeline

Financial Results and Operational Update for Half-Year Ended December 31, 2025 NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided financial results and an operational update for the period ended December 31, 2025 (H1 FY2026). FINANCIAL HIGHLIGHTS FOR H1 FY20261 Performance driven by successful commercial launch of Ryoncil®Total revenue of US$51.3 million (A$78.3 million),2 up from US$3.2 million. Successful U.S. commercial launch of Ryoncil® (remestemcel-L-rknd) generated gross sales of US$57.0 million and revenue of US$48.7 million after gross to net adjustment. Ryoncil® gross profit, excluding amortization, was US$44.2 million versus nil in the prior year period. Direct selling costs were US$7.7 million. The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.